Ulf Landegren

This inventor holds 29 USPTO granted patents and 10 published patent applications and 16 EPO patents, primarily in Nucleic Acid Technologies. Top assignees: Olink Ab, Navinci Diagnostics Ab, Quiatech Ab. Active years: 1997-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulf Landegren. Retrieved from https://idiyas.com/inventor/ulf-landegren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 10)

% Patents Active = 86.2

EPO Patents = 16 (Patent Applications = 19)

Average Co-Inventor Count = 2.1

ph-index = 17

Forward Citations = 1,616(Granted Patents)

Location History:

Upsala, SE (1997)
45 Uppsala, SE (2001)
46 Uppsala, SE (1999 - 2005)
Uppsala, SE (1998 - 2023)

Company Filing History:

Navinci Diagnostics Ab

Agilent Technologies, Inc.

patents

7. 10 out of 834,513

Other

patents

Years Active: 1997-2023

Loading Chart...

Areas of Expertise:

Nucleic Acid Amplification

Proximity Probes

Oligonucleotide Synthesis

Multiplexed Assays

Solid Phase Synthesis

Nucleic Acid Detection

Rolling Circle Replication

Target Sequence Selection

Ultrasensitive Immunoassays

Nucleic Acid Enrichment

Probing Techniques

Mismatched Detection

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11649486 - Double-stranded circle probes (2023-05-16),

2. 11352658 - Method for selecting a target nucleic acid sequence (2022-06-07),

3. 10612093 - Method for selecting a target nucleic acid sequence (2020-04-07),

4. 10597701 - Unfolding proximity probes and methods for the use thereof (2020-03-24),

5. 10465235 - Multiplexed proximity ligation assay (2019-11-05),

6. 10174366 - Localised RCA-based amplification method (2019-01-08),

7. 9551032 - Unfolding proximity probes and methods for the use thereof (2017-01-24),

8. 8664164 - Probes for specific analysis of nucleic acids (2014-03-04),

9. RE44265 - Nucleic acid amplification method (2013-06-03),

10. 8053188 - Nucleic acid enrichment (2011-11-08),

11. 7790388 - Nucleic acid amplification method (2010-09-07),

12. 7351528 - Probing of specific nucleic acids (2008-04-01),

13. 7320860 - Nucleic acid amplification method (2008-01-22),

14. 7306904 - Methods and kits for proximity probing (2007-12-11),

15. 7074564 - Rolling circle replication of padlock probes (2006-07-11),

Title: Ulf Landegren: A Pioneer in Nucleic Acid Probes

Introduction

Ulf Landegren, based in Uppsala, Sweden, is a distinguished inventor known for his extensive contributions to the field of molecular biology. With a remarkable portfolio of 29 patents, Landegren has focused on innovative methods for detecting nucleic acid molecules, significantly advancing research in diagnostics and genetic analysis.

Latest Patents

Among Landegren's latest inventions are two notable patents that address the detection of target nucleic acid sequences. The first patent discusses double-stranded circle probes designed for nucleic acid detection through an RCA reaction. These probes feature a first circular template strand, capable of acting as a template for RCA, while being protected from undesired reactions. The second patent outlines a method for selecting a target region of interest within a nucleic acid molecule using a specialized probe. This probe incorporates sequences that facilitate hybridization and amplification processes, enhancing accuracy in identifying specific nucleic acid targets.

Career Highlights

Landegren's career is marked by his pivotal role in developing groundbreaking nucleic acid technologies. His inventions have played a crucial part in enhancing the sensitivity and specificity of nucleic acid detection methods. His innovative approaches are widely recognized in both academic and industrial circles, contributing significantly to the advancement of molecular diagnostics.

Collaborations

Throughout his career, Ulf Landegren has collaborated with notable scientists, including Marek Kwiatkowski and Mats Nilsson. These partnerships have enabled Landegren to leverage diverse expertise and advance his research, further solidifying his reputation as a leading inventor in his field.

Conclusion

Ulf Landegren's contributions to the realm of molecular biology through his innovative patents highlight his impact on the scientific community. His work not only enhances our understanding of nucleic acid interactions but also paves the way for future advancements in diagnostics and research methodologies. With a commitment to innovation, Landegren continues to inspire the next generation of scientists and inventors.

Profile summary based on public USPTO records.